01515 CR MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.64X | Oper Margin | 7.8% |
|---|---|---|---|
| LT Debt/Equity | 2.2% | Net Margin | 5.4% |
| Total Debt/Equity | 13.0% | Return on Equity | 7.6% |
| Price/Book | 0.47X | Return on Assets | 3.8% |
| (HKD 2.690) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 552.04 | 601.81 | 284.01 | 298.08 | 511.15 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -8.3 | +111.9 | -4.7 | -41.7 | +38.9 |
| Earnings Per Share (HKD) | 0.437 | 0.476 | 0.225 | 0.236 | 0.407 |
| Earnings Per Share Growth (%) | -8.3 | +111.9 | -4.9 | -42.0 | +38.9 |
| Dividend Per Share (HKD) | 0.148 | 0.144 | 0.066 | 0.037 | 0.120 |
| P/E* (X) | 6.12 | 5.61 | 11.89 | 11.30 | 6.56 |
| Yield (%) | 5.55 | 5.38 | 2.47 | 1.39 | 4.49 |
| Dividend Share (%) | 33.97 | 30.19 | 29.39 | 15.66 | 29.48 |
| Book NAV (HKD) | 5.625 | 5.096 | 4.940 | 8.220 | 6.085 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-05-19 21:40:21
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 9,176 | 9,855 | -6.9 | 10,108 |
| Operating Result | 667.264 | 751.254 | -11.2 | 404.526 |
| Associates | 78.338 | 98.603 | -20.6 | 90.78 |
| Profit Before Taxation | 747.665 | 838.67 | -10.9 | 492.921 |
| Taxation | 191.567 | 166.923 | +14.8 | 165.031 |
| Profit /( Loss) After Taxation | 556.098 | 671.747 | -17.2 | 327.89 |
| Minority Interests | 60.154 | 105.872 | -43.2 | 70.21 |
| Net Profit | 495.944 | 565.875 | -12.4 | 257.68 |
| Earnings Per Share () | 0.4366 | 0.4760 | -8.3 | 0.2246 |
| Dividend Per Share () | 0.1483 | 0.1437 | +3.2 | 0.0660 |
| Announcement Date | 2026-03-24 | 2025-03-25 | NA | 2024-03-19 |
* Annualised
Last Update Time: 2026-05-19 21:40:26
